Printer-friendly version
ReliaTect® Post-Op Dressing with CHG provides broad-spectrum antimicrobial effect through proprietary Benehold™ CHG adhesive technology, absorbency for moisture management within a thin, conformable film, and transparency for visualization of the post-op site.
• CHG provides 99.99% (4-log) reduction of gram-negative and gram-positive bacteria and yeast for up to seven days
• Transparency provides visualization of the post-op site to allow monitoring and assessment, which may reduce frequency of dressing changes
• Absorbency allows for management of light to moderate wound exudate
• The dressing is waterproof, which supports patient's return to normal hygiene routine
ReliaTect® Post-Op Dressing with CHG is intended to cover and protect a wound caused by percutaneous medical devices such as drains, chest tubes, orthopedic pins, fixtures and wires. ReliaTect® may also be used to cover and secure a primary dressing. ReliaTect® inhibits microbial growth within the dressing and prevents external contamination.
ReliaTect® Post-Op Dressing with CHG should not be placed over infected wounds. ReliaTect® is not intended to treat surgical site infections (SSIs) or other percutaneous device-related infections.
ReliaTect® should not be used as a replacement for sutures and other primary wound closure methods. It should not be used on third-degree burns, on premature infants or infants younger than two months of age, or as a primary means to fix arterial catheters.
For external use only. Do not allow contact of this device with ears, eyes, mouth or mucous membranes.
Do not use this device on patients with a known hypersensitivity to chlorhexidine gluconate. If allergic reactions occur, discontinue use immediately and, if severe, contact a physician.
Stop using ReliaTect® if the patient experiences symptoms such as: wheezing or difficulty breathing, swelling of the face, hives that can quickly progress to more serious symptoms, severe rash or shock. These symptoms are associated with an allergic reaction to CHG.
Store in a cool, dry place. Keep away from direct sunlight. Do not use if packaging is damaged.
| Absorptive dressing format | |
| Alginate dressing format | |
| Antimicrobial effects up to 48 hours | |
| Antimicrobial effects up to 3 days | |
| Antimicrobial effects up to 7 days | ● |
| Bacterial binding | |
| Bacterial trapping | |
| Bactericidal | ● |
| Bactericidal broad-spectrum | ● |
| Bacteriostatic | |
| Collagen dressing format | |
| Composite dressing format | ● |
| Contact layer dressing format | |
| Foam dressing format | |
| Fungicidal | |
| Gauze or non-woven dressing format | |
| Gelling fiber dressing format | |
| Hydrogel (amorphous) dressing format | |
| Hydrogel (impregnated) dressing format | |
| Hydrogel (sheet) dressing format | |
| Impermeable to outside contaminants | ● |
| Impregnated dressing format | |
| Microbicidal | |
| Moisture vapor permeable | ● |
| Secondary dressing required | |
| Silicone-based adhesive | |
| Sporicidal | |
| Super absorbent polymers | |
| Sustained release formula | |
| Transparent film dressing format | |
| Virucidal | |
| Wound filler dressing format |
| Educational Material Available | ● |
| Free Samples/Trials Available | ● |
| Published Clinical Article Available | ● |
Non/Minimally Exudating Wounds
Surgical Wounds
Remove the dressing from the pouch using aseptic technique. Starting at the extended white tab, peel the bottom liner (marked 1) from the back of the dressing until the liner reaches a fold, exposing part of the adhesive surface. Apply the exposed adhesive area over the site and smooth dressing into place. Remove the remainder of the bottom liner and smooth the rest of the dressing into place making sure the dressing is secure. Break off the extended white tab at the dotted line and discard it. Document dressing change in accordance with facility protocols.
If infection is suspected, remove the dressing, inspect the site directly, and determine the appropriate medical intervention.
Change the dressing as necessary, in accordance with facility protocols. At a minimum, dressing should be changed at least every seven days, per CDC recommendations. The dressing should be changed sooner than seven days if: the dressing becomes loose, soiled or compromised in any way, the site is obscured or no longer visible, or there is visible drainage underneath the dressing.
Non-cytotoxic
Non-irritating
Eloquest Healthcare's specialized products serve as easy-to-use, cost-effective tools to improve outcomes for patients and caregivers alike, provide high quality support, and lower costs of care.